XML 69 R22.htm IDEA: XBRL DOCUMENT
v3.20.4

STOCK-BASED COMPENSATION | 12 Months Ended
--- | ---
Nov. 30, 2020
Share-based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION |
15. | STOCK-BASED COMPENSATION
2017 Plan The Company grants stock options and other stock-based awards under its 2017 Stock Option Plan (the “2017 Plan”). The maximum number of common stock which may be reserved for issuance under the 2017 plan is 18,993,274. The 2017 Plan is administered by the Compensation Committee of the Board. The Compensation Committee determines the persons to whom options to purchase shares of common stock, and other stock-based awards may be granted. Persons eligible to receive awards under the 2017 Plan are employees, officers, directors, and consultants of the Company. Awards are at the discretion of the Compensation Committee. Stock Options During the years ended November 30, 2020 and 2019, the Company granted options to purchase 4,342,500 shares and 120,000 shares, respectively, of common stock to its employees and directors. Those granted during the year ended November 30, 2020, 3,417,500 options vested immediately and 925,000 options will vest over three years. The Company recorded stock-based compensation expense for options granted to its employees and directors of $675,545 and $31,530 during the years ended November 30, 2020 and 2019, respectively. During the years ended November 30, 2020 and 2019, the Company granted options to purchase 193,000 shares and 0 shares, respectively, of common stock to non-employees. Those granted during the year ended November 30, 2020, 110,000 options vested immediately and 83,000 options will vest over one year. The Company recorded stock-based compensation expense for options granted to non-employees of $25,318 and $0 during the years ended November 30, 2020 and 2019, respectively. Stock Option Valuation The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and non-employees for the years ended November 30, 20120 and 2019 were as follows: Employee, Director and Non-Employee (Black-Scholes option pricing model)
|  | 2020 |  |  | 2019 |
Risk free rate |  |  | 0.00 – 1.68% |  |  |  | 2.00 | %
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 118 - 144% |  |  |  | 133 | %
Expected life |  |  | 2 - 5 years |  |  |  | 5 years |
Market price of the Company’s common stock on date of grant |  | $ | 0.19 – 1.48 |  |  | $ | 0.14 |
Exercise price |  | $ | 0.19 – 1.50 |  |  | $ | 0.14 |
The following table summarizes option activity under the 2017 Plan during the year ended November 30, 2020:
|  |  | Stock |  |  | Weighted-Average Exercise Price Per Stock Option |
|  |  | Options |  |  | CDN$ |  |  | USD$ |
Outstanding, November 30, 2018 |  |  |  | 6,376,667 |  |  |  | 0.22 |  |  |  | (0.18 | )
Granted |  |  |  | 120,000 |  |  |  | 0.19 |  |  |  | (0.14 | )
Expired |  |  |  | (1,270,000 | ) |  |  | 0.37 |  |  |  | (0.28 | )
Cancelled |  |  |  | (2,315,000 | ) |  |  | 0.22 |  |  |  | (0.17 | )
Outstanding, November 30, 2019 |  |  |  | 2,911,667 |  |  |  | 0.19 |  |  |  | 0.14 |
Granted |  |  |  | 4,535,500 |  |  |  | 0.42 |  |  |  | 0.33 |
Expired |  |  |  | (212,500 | ) |  |  | (0.28 | ) |  |  | (0.21 |
Exercised |  |  |  | (55,000 | ) |  |  | (0.25 | ) |  |  | (0.19 |
Cancelled |  |  |  | (120,000 | ) |  |  | (1.79 | ) |  |  | (1.38 |
Outstanding, November 30, 2020 |  |  |  | 7,059,667 |  |  |  | 0.24 |  |  |  | 0.31 |
Exercisable, November 30, 2020 |  |  |  | 5,059,667 |  |  |  |  |  |  |  |  |
Exercisable, November 30, 2019 |  |  |  | 1,411,667 |  |  |  |  |  |  |  |  |
The stock options outstanding at the end of the year had weighted-average contractual life as follows:
|  | 2020 |  |  | 2019 |
|  |  | (years) |  |  |  | (years) |
Total outstanding options |  |  | 3.76 |  |  |  | 4.3 |
Total exercisable options |  |  | 3.53 |  |  |  | 3.1 |
Incentive Warrants During the year ended November 30, 2019, the Company issued 750,000 incentive warrants each to two consultants to purchase common shares. The warrants were issued outside of the 2017 Plan and became fully vested in December 2019. In July 2020, the Company’s Board approved and the Company entered into an agreement with one of the consultants to allow a cashless exercise of 750,000 warrants at $0.155, resulting in the issuance of 683,190 common shares of the Company’s stock. See Note 14, “Shareholders’ Equity (Deficit),” for additional information. During the year ended November 30, 2020, the Company issued 150,000 incentive warrants valued at $7,969 with an exercise price of $0.25 per warrant in exchange for services to a marketing consultant to purchase common shares. The incentive warrants were issued outside of the 2017 Plan and were fully vested at issuance. Stock-based compensation expense for the warrants for the years ended November 30, 2020 and 2019 was $15,434 and $0, respectively. Incentive Warrant Valuation The assumptions that the Company used to determine the grant-date fair value of incentive warrants granted for the years ended November 30, 2020 and 2019 were as follows: (Black-Scholes option pricing model)
|  | 2020 |  |  | 2019 |
Risk free rate |  |  | 1.47 | % |  |  | 2.00 | %
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 57 | % |  |  | 149 | %
Expected life |  |  | 1.1 years |  |  |  | 3 years |
Market price of the Company’s common stock on date of grant |  | $ | 0.22 |  |  | $ | 0.16 |
Exercise price |  | $ | 0.25 |  |  | $ | 0.16 |
2020 Plan On October 23, 2020, the Company adopted the Byrna Technologies Inc. 2020 Equity Incentive Plan (the “2020 Equity Incentive Plan”). The aggregate number of shares of common stock available for issuance in connection with options and other awards granted under the 2020 Plan is 25,000,000. The 2020 Plan is administered by the Compensation Committee of the Board. The Compensation Committee determines the persons to whom options to purchase shares of common stock, stock appreciation rights (“SARs”), restricted stock units (“RSUs”), and restricted or unrestricted shares of common stock may be granted. Persons eligible to receive awards under the 2020 Equity Incentive Plan are employees, officers, directors, consultants, advisors and other individual service providers of the Company. Awards are at the discretion of the Compensation Committee. Restricted Stock Units Effective August 31, 2020, the Company granted the Chief Executive Officer 9,000,000 restricted stock unit awards (“RSUs”) under the 2020 Equity Incentive Plan. The RSUs shall have a “double trigger” for vesting based on stock price and time, as follows: (1) one-third of the RSUs will be triggered when the Company’s stock trades above $2.00 on a 20-day volume weighted average closing price (“VWAP”), the second one-third of the RSUs will be triggered when the Company’s stock trades above $3.00 on a 20-day VWAP, and the final one-third of the RSUs will be triggered when the stock trades above $4.00 on a 20-day VWAP and (2) the employee must remain employed by the Company for three years from the effective date for the RSUs to vest. During the year ended November 30, 2020, the Company granted employees 6,735,000 restricted stock unit awards (“RSUs”) under the 2020 Equity Incentive Plan. The RSUs shall have a “double trigger” for vesting based on stock price and time, as follows: (1) one-third of the RSUs are not subject to any performance trigger, the second one-third of the RSUs will be triggered when the Company’s stock trades above $3.00 on a 20-day VWAP, and the final one-third of the RSUs will be triggered when the stock trades above $4.00 on a 20-day VWAP and (2) the employee must remain employed by the Company for three years from the effective date for the RSUs to vest. Stock-based compensation expense for the RSUs for the years ended November 30, 2020 as $536,069. RSU Valuation The assumptions that the Company used to determine the grant-date fair value of RSUs granted for the year ended November 30, 2020 were as follows: (Monte Carlo simulation model)
|  | 2020 |
Risk free rate |  |  | 0.26 | %
Expected dividends |  |  | 0.00 | %
Expected volatility |  |  | 121 | %
Expected life |  |  | 3 years |
Market price of the Company’s common stock on date of grant |  | $ | 1.41 – 1.58 |
Exercise price |  | $ | 1.41 – 1.58 |
The following table summarizes the RSU activity during the year ended November 30, 2020:
|  |  | RSUs |  |  | Weighted-Average Exercise Price |
Outstanding, November 30, 2019 |  |  |  | — |  |  |  | — |
Granted |  |  |  | 15,735,000 |  |  |  | 1.55 |
Outstanding, November 30, 2020 |  |  |  | 15,735,000 |  |  |  | 1.55 |
Exercisable, November 30, 2020 |  |  |  | — |  |  |  | — |
Stock-Based Compensation Expense Total stock-based compensation expense of $1,252,366 and $218,154 for the years ended November 30, 2020 and 2019, respectively, were recorded in operating expenses in the accompanying Consolidated Statements of Operations and Comprehensive Loss. As of November 30, 2020 and 2019, there was $7,720,448 and $30,715, respectively, of unrecognized expense related to non-vested stock-based compensation arrangements granted. The weighted-average period over which total compensation cost related to non-vested awards not yet recognized is expected to be recognized is 2.77 and 1.4 years as of November 30, 2020 and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration